Vimarsana
Biggest News Aggregation in the World

Page 41 - Third Bancorp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Third Bancorp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Third Bancorp Today - Breaking & Trending Today

General Electric (NYSE:GE) Given New $201.00 Price Target at UBS Group - Vimarsana News

General Electric (NYSE:GE) Given New $201.00 Price Target at UBS Group

General Electric (NYSE:GE – Free Report) had its price objective increased by UBS Group from $191.00 to $201.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a buy rating on the conglomerate’s stock. Several other research analysts have also issued reports on GE. JPMorgan Chase & Co. increased […]

Travel + Leisure Co. (NYSE:TNL) Given Consensus Recommendation of "Moderate Buy" by Analysts - Vimarsana News

Travel + Leisure Co. (NYSE:TNL) Given Consensus Recommendation of "Moderate Buy" by Analysts

Travel + Leisure Co. (NYSE:TNL – Get Free Report) has received an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price […]

Antero Resources Co. (NYSE:AR) Given Average Rating of "Moderate Buy" by Analysts - Vimarsana News

Antero Resources Co. (NYSE:AR) Given Average Rating of "Moderate Buy" by Analysts

Shares of Antero Resources Co. (NYSE:AR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the thirteen analysts that are covering the company, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong […]

Source: wkrb13.com
Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of "Moderate Buy" from Analysts - Vimarsana News

Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of "Moderate Buy" from Analysts

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has received a consensus rating of “Moderate Buy” from the seventeen brokerages that are currently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 12 month price objective among […]

Raymond James Reaffirms Strong-Buy Rating for Toll Brothers (NYSE:TOL) - Vimarsana News

Raymond James Reaffirms Strong-Buy Rating for Toll Brothers (NYSE:TOL)

Raymond James reaffirmed their strong-buy rating on shares of Toll Brothers (NYSE:TOL – Free Report) in a report published on Thursday morning, Benzinga reports. They currently have a $145.00 price objective on the construction company’s stock, up from their previous price objective of $135.00. TOL has been the subject of a number of other reports. […]